How Pfizer used AI and supercomputers to design COVID-19 vaccine, tablet AI algorithms were involved in every step of the way to design and deliver Pfizer's COVID-19 vaccine and antiviral tablets to hundreds of millions of people as coronavirus spread around the world. Lidia Fonseca, Pfizer's chief digital and technology officer, said machine-learning technology was crucial in speeding up the …
Indeed, not only that... but organisations like the Diamond Light Source or XFEL in Germany use micro-crystallography to work out how proteins look and then see which compounds could fit into the 'sockets' to deactivate (or activate) said proteins (and by extension work out what gene expression to engineer).
Science on the atomic/molecular level is just so utterly.
Perhaps Pfizer AI introduced the built in obscelecense?
The various vaccines saved a huge number of lives. But it was shocking how ineffective they were in preventing reinfection with variants and the short time protection lasts.
Not what it said on the tin.
Generally in BigPharma* R & D is split into two parts (with a fuzzy bit in the middle). Research is where molecules are discovered and Development is where the drugs are tested in humans and where they work out how to make said drug at scale. In this case I think the Research was in Biontech, the development in Pfizer.
* I work for a competitor to Pfizer.
The Register 
Biting the hand that feeds IT
Copyright. All rights reserved © 1998–2024
